Literature DB >> 16395414

The role of chronic infection and inflammation in the pathogenesis of cardiovascular and cerebrovascular disease.

Marina Diomedi1, Giorgia Leone, Antonio Renna.   

Abstract

Molecular and cellular immune activities have a fundamental role in all stages of the atherosclerotic process and in the pathogenesis of cerebrovascular and cardiovascular diseases. Recent studies have demonstrated how chronic infections can support a local and systemic chronic inflammation, leading to the atherosclerotic process. The pathogenic link between infection and cardiovascular and cerebrovascular disease is not completely defined. Some therapeutic strategies, able to influence the persistence of the infections or to modify the inflammatory process, could be useful in primary and secondary vascular disease prevention and in modifying the acute event outcome. Copyright (c) 2005 Prous Science. All rights reserved.

Entities:  

Mesh:

Year:  2005        PMID: 16395414     DOI: 10.1358/dot.2005.41.11.917342

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  4 in total

1.  The biology of aging and frailty.

Authors:  Neal S Fedarko
Journal:  Clin Geriatr Med       Date:  2011-02       Impact factor: 3.076

2.  Serum markers of apoptosis decrease with age and cancer stage.

Authors:  Nilay Kavathia; Alka Jain; Jeremy Walston; Brock A Beamer; Neal S Fedarko
Journal:  Aging (Albany NY)       Date:  2009-07-14       Impact factor: 5.682

3.  β2-Microglobulin is a Novel and Reliable Biomarker for Predicting Ischemic Stroke Recurrence: A Prospective Cohort Study.

Authors:  Fu-Yong Hu; Wentao Wu; Qiuwan Liu; Juncang Wu; Hualing Guo; Jing Yang; Zhuqing Wu; Ke Jiang; Guoping Wang; Yu Qian; Wei Ge; Sen Qun
Journal:  Front Pharmacol       Date:  2022-06-17       Impact factor: 5.988

4.  Results from a hypothesis generating case-control study: herpes family viruses and schizophrenia among military personnel.

Authors:  David W Niebuhr; Amy M Millikan; Robert Yolken; Yuanzhang Li; Natalya S Weber
Journal:  Schizophr Bull       Date:  2007-12-21       Impact factor: 9.306

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.